SUBSTITUTED N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)ARYLSULFONAMIDE ANALOGS AS MODULATORS OF CEREBLON PROTEIN
In one aspect, the disclosure relates to substituted N-(2-(2,6-dioxopiperidinyl-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs that useful as modulators of cereblon (CRBN) activity, methods of making same, pharmaceutical compositions comprising same, and methods of treating various clinical...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | KERAMATNIA, Fatemeh FISHER, Marcus MCGOWAN, Kevin MULLIGHAN, Charles G CHANG, Yunchao RANKOVIC, Zoran PRICE, Jeanine NISHIGUCHI, Gisele A Das, Sourav MIN, Jaeki |
description | In one aspect, the disclosure relates to substituted N-(2-(2,6-dioxopiperidinyl-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs that useful as modulators of cereblon (CRBN) activity, methods of making same, pharmaceutical compositions comprising same, and methods of treating various clinical conditions and disorders using same, e.g., a disorder of uncontrolled cellular proliferation, such as a cancer, which may be associated with cereblon protein dysfunction and/or a GSPT1 dysfunction. In various further aspects, the disclosed compounds can selectively modulate the degradation of GSPT1 protein, i.e., the disclosed compounds can act as GSPT1 degraders. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024132463A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024132463A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024132463A13</originalsourceid><addsrcrecordid>eNqNyr0KwjAYheEuDqLeQ8BFoQGb1O5pk-oHMV_JD9ipFImTaKGu3rsVvQDhwDs8Z568XCidBx-8ksTQDZuWFlQCnrGBRlmQYCinrd7SLOVfAIdgJOpJ9h8RttUu6BqNOIFURBih8eCIcOSEMmjh0TqCNamUVaVGQxqLXoFZJrNrfxvj6tdFsq6Vr440Do8ujkN_iff47IJjO5ZnnOUFFxn_7_UGR9w7zw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)ARYLSULFONAMIDE ANALOGS AS MODULATORS OF CEREBLON PROTEIN</title><source>esp@cenet</source><creator>KERAMATNIA, Fatemeh ; FISHER, Marcus ; MCGOWAN, Kevin ; MULLIGHAN, Charles G ; CHANG, Yunchao ; RANKOVIC, Zoran ; PRICE, Jeanine ; NISHIGUCHI, Gisele A ; Das, Sourav ; MIN, Jaeki</creator><creatorcontrib>KERAMATNIA, Fatemeh ; FISHER, Marcus ; MCGOWAN, Kevin ; MULLIGHAN, Charles G ; CHANG, Yunchao ; RANKOVIC, Zoran ; PRICE, Jeanine ; NISHIGUCHI, Gisele A ; Das, Sourav ; MIN, Jaeki</creatorcontrib><description>In one aspect, the disclosure relates to substituted N-(2-(2,6-dioxopiperidinyl-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs that useful as modulators of cereblon (CRBN) activity, methods of making same, pharmaceutical compositions comprising same, and methods of treating various clinical conditions and disorders using same, e.g., a disorder of uncontrolled cellular proliferation, such as a cancer, which may be associated with cereblon protein dysfunction and/or a GSPT1 dysfunction. In various further aspects, the disclosed compounds can selectively modulate the degradation of GSPT1 protein, i.e., the disclosed compounds can act as GSPT1 degraders. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240425&DB=EPODOC&CC=US&NR=2024132463A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240425&DB=EPODOC&CC=US&NR=2024132463A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KERAMATNIA, Fatemeh</creatorcontrib><creatorcontrib>FISHER, Marcus</creatorcontrib><creatorcontrib>MCGOWAN, Kevin</creatorcontrib><creatorcontrib>MULLIGHAN, Charles G</creatorcontrib><creatorcontrib>CHANG, Yunchao</creatorcontrib><creatorcontrib>RANKOVIC, Zoran</creatorcontrib><creatorcontrib>PRICE, Jeanine</creatorcontrib><creatorcontrib>NISHIGUCHI, Gisele A</creatorcontrib><creatorcontrib>Das, Sourav</creatorcontrib><creatorcontrib>MIN, Jaeki</creatorcontrib><title>SUBSTITUTED N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)ARYLSULFONAMIDE ANALOGS AS MODULATORS OF CEREBLON PROTEIN</title><description>In one aspect, the disclosure relates to substituted N-(2-(2,6-dioxopiperidinyl-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs that useful as modulators of cereblon (CRBN) activity, methods of making same, pharmaceutical compositions comprising same, and methods of treating various clinical conditions and disorders using same, e.g., a disorder of uncontrolled cellular proliferation, such as a cancer, which may be associated with cereblon protein dysfunction and/or a GSPT1 dysfunction. In various further aspects, the disclosed compounds can selectively modulate the degradation of GSPT1 protein, i.e., the disclosed compounds can act as GSPT1 degraders. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyr0KwjAYheEuDqLeQ8BFoQGb1O5pk-oHMV_JD9ipFImTaKGu3rsVvQDhwDs8Z568XCidBx-8ksTQDZuWFlQCnrGBRlmQYCinrd7SLOVfAIdgJOpJ9h8RttUu6BqNOIFURBih8eCIcOSEMmjh0TqCNamUVaVGQxqLXoFZJrNrfxvj6tdFsq6Vr440Do8ujkN_iff47IJjO5ZnnOUFFxn_7_UGR9w7zw</recordid><startdate>20240425</startdate><enddate>20240425</enddate><creator>KERAMATNIA, Fatemeh</creator><creator>FISHER, Marcus</creator><creator>MCGOWAN, Kevin</creator><creator>MULLIGHAN, Charles G</creator><creator>CHANG, Yunchao</creator><creator>RANKOVIC, Zoran</creator><creator>PRICE, Jeanine</creator><creator>NISHIGUCHI, Gisele A</creator><creator>Das, Sourav</creator><creator>MIN, Jaeki</creator><scope>EVB</scope></search><sort><creationdate>20240425</creationdate><title>SUBSTITUTED N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)ARYLSULFONAMIDE ANALOGS AS MODULATORS OF CEREBLON PROTEIN</title><author>KERAMATNIA, Fatemeh ; FISHER, Marcus ; MCGOWAN, Kevin ; MULLIGHAN, Charles G ; CHANG, Yunchao ; RANKOVIC, Zoran ; PRICE, Jeanine ; NISHIGUCHI, Gisele A ; Das, Sourav ; MIN, Jaeki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024132463A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KERAMATNIA, Fatemeh</creatorcontrib><creatorcontrib>FISHER, Marcus</creatorcontrib><creatorcontrib>MCGOWAN, Kevin</creatorcontrib><creatorcontrib>MULLIGHAN, Charles G</creatorcontrib><creatorcontrib>CHANG, Yunchao</creatorcontrib><creatorcontrib>RANKOVIC, Zoran</creatorcontrib><creatorcontrib>PRICE, Jeanine</creatorcontrib><creatorcontrib>NISHIGUCHI, Gisele A</creatorcontrib><creatorcontrib>Das, Sourav</creatorcontrib><creatorcontrib>MIN, Jaeki</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KERAMATNIA, Fatemeh</au><au>FISHER, Marcus</au><au>MCGOWAN, Kevin</au><au>MULLIGHAN, Charles G</au><au>CHANG, Yunchao</au><au>RANKOVIC, Zoran</au><au>PRICE, Jeanine</au><au>NISHIGUCHI, Gisele A</au><au>Das, Sourav</au><au>MIN, Jaeki</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)ARYLSULFONAMIDE ANALOGS AS MODULATORS OF CEREBLON PROTEIN</title><date>2024-04-25</date><risdate>2024</risdate><abstract>In one aspect, the disclosure relates to substituted N-(2-(2,6-dioxopiperidinyl-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs that useful as modulators of cereblon (CRBN) activity, methods of making same, pharmaceutical compositions comprising same, and methods of treating various clinical conditions and disorders using same, e.g., a disorder of uncontrolled cellular proliferation, such as a cancer, which may be associated with cereblon protein dysfunction and/or a GSPT1 dysfunction. In various further aspects, the disclosed compounds can selectively modulate the degradation of GSPT1 protein, i.e., the disclosed compounds can act as GSPT1 degraders. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2024132463A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | SUBSTITUTED N-(2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-5-YL)ARYLSULFONAMIDE ANALOGS AS MODULATORS OF CEREBLON PROTEIN |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T19%3A59%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KERAMATNIA,%20Fatemeh&rft.date=2024-04-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024132463A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |